FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Peptide Therapy Doctors Supplement Store The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA's Overreach on Compounded Peptides